The breast lesion excision system procedure: An optimal solution for the management of indeterminate BI-RADS category 3 breast lesions in women with severe anxiety

Hot, Semih; Coskun, Zafer Unsal; Akçakaya, Adem; Bender, Ömer; Türkmen, Ülkü Aygen; Nayır, Pınar Özay; Sarı, Ayhan; Hot, A.

doi:10.15537/smj.2018.9.22573

Cited by 5 publications

(4 citation statements)

References 22 publications

(36 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Krainick-Strobel et al as well as Liu et al reported that the VAB biopsy was associated with a low risk of side effects, such as hematoma at the biopsy site in 5.52% of cases, which did not require a surgical intervention [9,10]. The same results can be found in studies analyzing complications of the BLES procedure with occurrence of hematoma at the biopsy site not requiring intervention in 4.2-5.5% of cases [11][12][13][14]. Our study did not reveal any severe early or late side effects requiring intervention, either in the VAB or the BLES biopsy patients.…”

Section: Discussionmentioning

confidence: 77%

Comparison of two minimally invasive biopsy techniques – Breast Lesion Excision System and vacuum-assisted biopsy – for diagnosing and treating breast lesions

Brzuszkiewicz

Hodorowicz-Zaniewska

Miękisz³

et al. 2019

Arch Med Sci

View full text Add to dashboard Cite

Introduction: The vacuum-assisted biopsy (VAB) and the Breast Lesion Excision System (BLES) are minimally invasive biopsy techniques, both used as diagnostic and therapeutic tools. The aim of the study is to compare these two methods and assess them in the context of discomfort, early and late complications and their diagnostic and therapeutic potential. Material and methods: The study involved 173 patients who underwent a VAB or a BLES breast biopsy in the period between 2009 and 2016. Approximately 3 months after the biopsy, the patients completed a questionnaire in which they assessed the procedure for discomfort associated with the procedure and the final cosmetic outcome. The cosmetic effect of the biopsy was also assessed by a surgeon. Results: The BLES and the VAB breast biopsies did not differ in terms of pain, duration, and discomfort of the procedure, breast bruising, breast tenderness about 24 h after the procedure or pain lasting over 3 months after the biopsy. Subsequently, the biopsies were evaluated in terms of the cosmetic effect assessed by the patient and by a surgeon and no differences were observed. There were no significant differences between the VAB and the BLES breast biopsies in the course of the procedure, early and late complications and cosmetic effect. Conclusions: Since the BLES breast biopsy makes it possible to evaluate the margins, it is a good alternative to the open breast biopsy.

show abstract

Section: Discussionmentioning

confidence: 77%

Comparison of two minimally invasive biopsy techniques – Breast Lesion Excision System and vacuum-assisted biopsy – for diagnosing and treating breast lesions

Brzuszkiewicz

Hodorowicz-Zaniewska

Miękisz³

et al. 2019

Arch Med Sci

View full text Add to dashboard Cite

show abstract

“…If we can screen category 3 and category 4 of patients and observe the low-risk lesions regularly, the unnecessary invasive examination can be reduced 5,6 . If these low-risk breast lesions affect the patient's daily life and physical and mental health, surgical resection is generally recommended 7 .…”

Section: Introductionmentioning

confidence: 99%

Risk factors of breast malignant lesions in patients with ultrasound BI-RADS 3, 4a and 4b undergoing Mammotome minimally invasive surgery

Zhu

Dou

Liu

et al. 2023

Preprint

View full text Add to dashboard Cite

Background To sort out the basic data and imaging examination results of the patients who underwent the Mammotome minimally invasive surgery, and explore the high-risk underlying factors related to cancerization, in order to optimize the minimally invasive surgery population, and reduce the malignant rate. Methods A total of 1188 female patients who came to our hospital from November 2016 to August 2021 for the Mammotome minimally invasive surgery were analyzed retrospectively. According to the inclusion criteria, the clinical data of 1158 patients and 2164 lesions were finally obtained. We summarized the benign and malignant lesions of BI-RADS category 3, BI-RADS category 4a and BI-RADS category 4b by conventional ultrasound, and got 1562, 578 and 24 lesions respectively. By analyzing the clinical basic data, imaging features and pathological diagnosis of patients, the differences between benign and malignant lesions of these three types were evaluated. Results The malignant rates of BI-RADS category 3, BI-RADS category 4a and BI-RADS category 4b patients who underwent the Mammotome minimally invasive surgery were 0.6%(9/1562), 6.4%(37/578) and 8.3%(2/24) respectively. According to statistics, the age of patients with BI-RADS category 3 is generally younger than that of patients with category 4a and category 4b. Comparing all the three types of lesions in pairs, we found that there were statistical differences in the presence or absence of blood flow signals and the status of calcified lesions, among which category 4b blood flow signal accounted for the highest proportion. Among the category 3 of lesions, we also found that the age of menarche in patients with malignant lesions is younger compared with benign lesions. In category 4a lesions, the patients with malignant lesions were older and mainly concentrated between 40 and 50 years old, and the maximum diameter of the lesions was larger. Whether it is category 3 or category 4a malignant lesions, mammography shows that the incidence of category 4a and multifocal calcification is higher. Conclusion Combined with the clinical data and imaging examination results, BI-RADS category 3 patients have excellent results in choosing Mammotome minimally invasive surgery. Patients with BI-RADS category 4a should be alert to the following factors, including age between 40 and 50, older menarche age, lesion site in the outer upper quadrant, mammography grade of 4a or above, and presence of calcification. Minimally invasive surgery is not recommended for patients diagnosed as BI-RADS category 4b.

show abstract

“…The unnecessary invasive examination can be minimized by screening and observing category 3 and category 4a patients on a regular basis ( 7 , 8 ). Surgical resection is typically advised if the patient’s daily life, physical health, or mental health are affected by these low-risk breast lesions ( 9 ).…”

Section: Introductionmentioning

confidence: 99%

Vacuum-assisted biopsy system for breast lesions: a potential therapeutic approach

Zhu,

Chen,

Dou

et al. 2023

Front. Oncol.

View full text Add to dashboard Cite

PurposeThe primary objective is to optimize the population eligible for Mammotome Minimally Invasive Surgery (MIS) by refining selection criteria. This involves maximizing procedure benefits, minimizing malignancy risk, and reducing the rate of malignant outcomes.Patients and methodsA total of 1158 female patients who came to our hospital from November 2016 to August 2021 for the Mammotome MIS were analyzed retrospectively. Following χ2 tests to screen for risk variables, binary logistic regression analysis was used to determine the independent predictors of malignant lesions. In addition, the correlation between age and lesion diameter was investigated for BI-RADS ultrasound (US) category 4a lesions in order to better understand the relationship between these variables.ResultsThe malignancy rates of BI-RADS US category 3, category 4a and category 4b patients who underwent the Mammotome MIS were 0.6% (9/1562), 6.4% (37/578) and 8.3% (2/24) respectively. Malignant lesions were more common in patients over the age of 40, have visible blood supply, and BI-RADS category 4 of mammography. In BI-RADS US category 4a lesions, the diameter of malignant tumor was highly correlated with age, and this correlation was strengthened in patients over the age of 40 and with BI-RADS category 4 of mammography.ConclusionThe results of this study demonstrate that the clinical data and imaging results, particularly age, blood supply, and mammography classification, offer valuable insights to optimize patients’ surgical options and decrease the incidence of malignant outcomes.

show abstract

The breast lesion excision system procedure: An optimal solution for the management of indeterminate BI-RADS category 3 breast lesions in women with severe anxiety

Cited by 5 publications

References 22 publications

Comparison of two minimally invasive biopsy techniques – Breast Lesion Excision System and vacuum-assisted biopsy – for diagnosing and treating breast lesions

Comparison of two minimally invasive biopsy techniques – Breast Lesion Excision System and vacuum-assisted biopsy – for diagnosing and treating breast lesions

Risk factors of breast malignant lesions in patients with ultrasound BI-RADS 3, 4a and 4b undergoing Mammotome minimally invasive surgery

Vacuum-assisted biopsy system for breast lesions: a potential therapeutic approach

Contact Info

Product

Resources

About